The COVID-19 vaccines are here: What comes next?
From McKinsey:
As vaccine availability nears, communities and consumers will want answers to many questions, including:
- Is the vaccine effective and safe?
- Who will get vaccinated first?
- Which vaccine will we receive, especially if multiple vaccines are available?
- Where and when can we get vaccinated?
- Will we have to pay?
- Above all, what do we need to worry about?
Although the scale of the task may seem daunting, countries benefit by starting end-to-end planning immediately. Our 6A framework lays out a structured approach to ensure vaccines are available, administrable, accessible, acceptable, affordable, and accountable while taking into account strategic considerations associated with uncertainty (for example, vaccine clinical and technical profile) and building system capabilities (Exhibit 2). We have developed, in granular detail, the individual activities and considerations behind each component of the framework. Through the collective initial effort of the pharma industry, the scientific community, global health institutions, and governments, most elements of the “available” segment of the 6A journey are being addressed
